levonorgestrel has been researched along with antipyrine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Ehnholm, C; Heikkinen, JE; Luoma, PV; Ylöstalo, PR | 1 |
| Bartoli, A; Barzaghi, N; Cipolla, G; Fattore, C; Gatti, G; Mumford, J; Perucca, E; Veliz, G | 1 |
1 trial(s) available for levonorgestrel and antipyrine
| Article | Year |
|---|---|
A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers.
Topics: Adult; Anticonvulsants; Antipyrine; Aryl Hydrocarbon Hydroxylases; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Interactions; Enzyme Induction; Estradiol Congeners; Ethinyl Estradiol; Female; gamma-Aminobutyric Acid; gamma-Glutamyltransferase; Half-Life; Humans; Levonorgestrel; Microsomes, Liver; Oxidoreductases, N-Demethylating; Placebos; Vigabatrin | 1997 |
4 other study(ies) available for levonorgestrel and antipyrine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function.
Topics: Adult; Antipyrine; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metabolic Clearance Rate; Microsomes, Liver; Norgestrel; Triglycerides | 1987 |